Exicure Partners with GPCR Therapeutics to Fuel Growth in Biotech
27 Dec 2024 //
BUSINESSWIRE
GPCR Announces Publication in PNAS Using Cutting Edge Spectroscopy
01 Apr 2024 //
BUSINESSWIRE
GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics
14 Dec 2023 //
GLOBENEWSWIRE
GPCR Announces Publication on Improving Hematopoietic Stem Cell Mobilization
26 Oct 2023 //
GLOBENEWSWIRE
GPCR Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1
10 Oct 2023 //
GLOBENEWSWIRE